International Patent: CELL TYPE - ANTIGEN MARKER DETECTION IN CELL SAMPLES FROM THOSE SUSPECTED OF MCI OR ALZHEIMER'S DISEASE

GENEVA, July 18 -- THE CLEVELAND CLINIC FOUNDATION filed a patent application (US2026/010467) for “CELL TYPE - ANTIGEN MARKER DETECTION IN CELL SAMPLES FROM THOSE SUSPECTED OF MCI OR ALZHEIMER'S DISEASE”. With publication no. WO/2026/151791, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: G01N 33/68

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....